The recent FDA accelerated approval of lifileucel, known commercially as Amtagvi, marks a groundbreaking development in cancer therapy. This treatment is the first of its kind, a tumor-derived autologous T cell immunotherapy, specifically targeting patients with...
As we navigate the chilly months of winter, we’re not just braving the cold but also a variety of respiratory illnesses, including COVID-19. Recent trends indicate a slight decrease in COVID-19 cases. For instance, hospital admissions have dropped from around...
Protecting Our Furry Companions at the 40th Annual Veterinary Meeting & Expo (VMX) In 2023, we estimate that 76 million US pet owners will be infected with COVID-19, making the COVID Pet Test™ a vital tool in the fight against COVID-19”— John Cataldi, CEO of Clear...
As various strains of Omicron have started popping up all over the US, New England has specifically seen a jump in BQ.1 and BQ.1.1: “New England has seen a rapid rise in the frequency of new immune-evading COVID-19 variants BQ.1 and BQ.1.1, with...
Each day we move closer to the next wave of COVID, here’s the latest about the new variants and what to expect this coming season: “An omicron subvariant is once again demonstrating immune-dodging abilities, posing a threat to both vaccinated and...
Here’s what we know about the latest omicron variant’s emergence in the United States: “XBB—a new, extremely immune-evasive Omicron variant surging in Singapore—hasn’t yet been detected in the U.S. But its child has. XBB.1 was first detected in the...
